Most of what I am reading suggests that in the future there will be significant staffing reductions at the FDA. There is a lot of research being done now with regard to Parkinson's and if this research yields some therapeutic results one has to wonder if this will slow down the approval and availability of most helpful interventions.
the future of care in the US: Most of what... - Cure Parkinson's
the future of care in the US
Written by
Boscoejean
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Research in to the benefits of singing
https://www.fmhs.auckland.ac.nz/faculty/cbr/about/choir.aspx
Hi there. Recently there was an...
Living with an Uncertain Future
We know Parkinson's is incurable and progressive. What we don't know is how it will progress in...
Most of the research papers are just pieces of trash
I have been exploring the PD research for quite some time. I have found that most of these so...
Improving the Bio-availability of Levodopa
This is a simplified version of my research into how L-Dopa is metabolised in humans and my current...
Me & Parkinson's & Future
Dear All,
My name is Jagdeep aged 53
My Diagnosis:
I started to get a tremor in my right hand in...
Related Posts
PD research: What is the problem?
Interview of Daphne Bryan following the publication of her book: “Parkinson’s and the B1 therapy”.
Feedback from a PD research scientist in the department of Clinical Neuroscience at the University of Cambridge (UK), on PASADENA Trial...
Anyone in the UK interested in a webinar entitled “Getting Involved in Trials and the PD Community”?
Atrazine a common herbicide is neurotoxic; it reduces dopamine levels in the substantia nigra.
